US Patent Issued to Medtronic MiniMed on Nov. 11 for "Methods and systems for inhibiting foreign-body responses in diabetic patients" (California Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,617, issued on Nov. 11, was assigned to Medtronic MiniMed Inc. (Northridge, Calif.).

"Methods and systems for inhibiting foreign-body responses in diabetic patients" was invented by Sarnath Chattaraj (Simi Valley, Calif.), Kiem H. Dang (Thousand Oaks, Calif.), Hsi Chung Fusselman (Simi Valley, Calif.), Poonam S. Gulati (La Canada, Calif.), Lance P. Hoffman (West Hollywood, Calif.) and Guangping Zhang (Calabasas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated ...